Tag: physical sciences
-
Small Biz Grant Funds Superbug Therapy Technology
A company designing synthetic viruses that attack antibiotic-resistant bacteria is receiving National Science Foundation funds to advance its work.
-
Biotechs Partner on Agitation Detection Technology
Two developers of treatments and tools for neurological diseases are developing a system for early detection of agitation, a symptom of psychiatric disorders.
-
Trial Shows Synthetic Antibody Slows Cognitive Decline
Results show a synthetic antibody reduces the rate of cognitive decline, one of two measures in a clinical trial of patients with mild to moderate Alzheimer’s disease.
-
Trial Shows Wearable Device Monitors Heart Rhythm Indicators
Results from a clinical trial show a device worn on the wrist can measure two key indicators of heart health as accurately as an electrocardiogram.
-
Small Biz Grant to Advance Cancer Chemotherapy Patch
A medical device company is receiving a small business grant from NIH to commercialize a patch that delivers chemotherapy directly to oral tumors.
-
Nasal Spray Shown to Stop Covid-19 Infection, Disease
An antiviral nasal spray is shown in tests with lab mice to prevent infection from SARS-CoV-2 viruses and reduce disease-causing cytokines.
-
AI-Analyzed Liquid Biopsy IDs Early Lung Cancer
A blood test analyzed with algorithms is shown to detect more than 90 percent of early-stage lung cancer cases in people at high risk of the disease.
-
RNA Manufacturer Goes Public in $282M Merger
A company producing synthetic RNA for agricultural and biomedical applications is now a public company after a special-purpose acquisition.
-
Portable Testing Device IDs Covid-19 Variants
A low-cost device is being developed that analyzes saliva samples for SARS-CoV-2 viral mutations, and returns results in about one hour.
-
Protein Chemistry Biotech Acquired in $2B Deal
Drug maker Bayer is acquiring a company discovering new therapies with a technology that reveals complex protein targets considered difficult to address.